Cipla reported Q4FY26 consolidated revenue of INR 6,541 Cr and PAT of INR 555 Cr, with margins impacted by headwinds.
Full-year FY26 revenue reached a record INR 28,163 Cr, though EBITDA declined to INR 5,925 Cr from INR 7,128 Cr in FY25.
Strategic highlights include a net cash position exceeding $1 billion, multiple new product launches, and key partnerships with Eli Lilly and MannKind.
The company advanced its ESG goals, achieving an 83% reduction in Scope 1 & 2 emissions and water positivity in Indian operations.